Healthcare Regulatory Environment in Nigeria and Ghana, 2018
Healthcare Regulatory Environment in Nigeria and Ghana, 2018
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
13-Dec-2018
Africa
$1,500.00
Special Price $1,125.00 save 25 %
Description
The West African region has a handful of emerging economies within Sub-Saharan Africa in terms of overall development and growth. The region currently has a high number of people living in extreme poverty, particularly in Nigeria, as well as a high population density. Furthermore, there has been a growing trend of non-communicable diseases, such as cancer and diabetes, which pose an additional strain on the healthcare systems of the respective countries. Despite positive developments in healthcare over the past decade, the health sector currently faces a number of regulatory challenges. These have a knock-on effect on the rest of the economy, requiring smart prioritisation of available resources. While various health strategies have been enforced across different countries in the region, their levels of success have been somewhat marginal. A deeper understanding of the different regulations covering key sectors and their successes and/or failures is highlighted in this study. Significant investment in healthcare and its allied industries’ for these two countries can be realised by unpacking the respective regulations in the sub-sectors of the healthcare market, assessing the history, development trends, future plans and future impact. Furthermore, the required areas of transformation can be realised using this research deliverable. Although some sub-sectors’ regulations are more advanced than others, the regulatory aspects and impact cannot be separated. It is therefore necessary to understand the market as a whole, with cross-sector opportunities, particularly given the competition arriving from other African regions.
Research Scope
The study covers the following healthcare segments: public health, healthcare finance, pharmaceuticals, medical devices, eHealth.
Research Highlights
- History of the regulatory environment in selected countries
- Key public health legislation and policy
- Key healthcare financing legislation and policy
- Key pharmaceutical and medical device legislation and policy
- Strategic recommendations and future outlook and impact of healthcare regulations
Key Issues Addressed
- How is the regulatory environment structured in Nigeria and Ghana?
- What are the key policies driving healthcare transformation in Nigeria and Ghana?
- What are the key regulatory bodies in the healthcare markets of Nigeria and Ghana?
- What has been the roadmap of healthcare regulations in Nigeria and Ghana?
- What is the future of healthcare regulations in Nigeria and Ghana?
- What are the key growth opportunities that arise as a result of healthcare regulations’ transformation?
Table of Contents
Key Findings
Scope
Key Questions this Study will Answer
Abbreviations and Definitions
Defining Healthcare Regulatory Impact
Summary—Nigeria
Summary—Ghana
Healthcare Market and Indicators
Public and Private Health Segmentation
Health Expenditure
Universal Healthcare and Funding
Private Health Insurance
Health Policy Growth and Development
Health Regulatory Bodies and Key Regulations
Public Health Regulations
Pharmaceuticals and Medical Technology Regulations
Health Insurance and Funding Regulations
eHealth Regulations
Healthcare Market and Indicators
Public and Private Health Segmentation
Health Expenditure
Universal Healthcare and Funding
Private Health Insurance
Health Policy Growth and Development
Health Regulatory Bodies and Key Regulations
Public Health Regulations
Pharmaceuticals and Medical Technology Regulations
Health Insurance and Funding Regulations
eHealth Regulations
Growth Opportunity 1—Public-Private Partnerships
Growth Opportunity 2—Training and Development
Growth Opportunity 3—Regulatory Development
Strategic Imperatives for Healthcare Stakeholders
The Last Word—3 Big Predictions
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Research Scope
The study covers the following healthcare segments: public health, healthcare finance, pharmaceuticals, medical devices, eHealth.
Research Highlights
- History of the regulatory environment in selected countries
- Key public health legislation
No Index | No |
---|---|
Podcast | No |
Author | Takudzwa Musiyarira |
Industries | Healthcare |
WIP Number | 9AB9-00-AF-00-00 |
Is Prebook | No |
GPS Codes | 9600-B1,9612-B1,9825-B1,99BD-B1,9837-B1 |